×

postmarket

Magnifying glass copy

TGA Publishes updated MDIR Guide

By Grant Bennett | 10.31.2019
Last week, the Australian regulator, the Therapeutic Goods Administration (TGA) published an updated guidance for Australian Sponsors and Manufacturers for the reporting of adverse events in Australia (Medical device incident...
Gandalf

New Zealand WANDers towards increased device regulation

By Arthur Brandwood | 12.21.2018
If you are WANDering about the title of this blog, yes, it’s a dreadful pun I know – but it’s that time of year. New Zealand’s Medsafe have issued a...
Uncertainty

Risk vs. Benefit FDA guidance gets to grips with uncertainty

By Arthur Brandwood | 09.27.2018
Doing risk management in an uncertain world is why regulatory affairs are as much art as science. Innovators will continue to push the envelope of the possible while regulators will...

Search

Recent Posts

TGA acceptance of international device reviews – clearing the fog

Dec 20, 2019

Brexit appears inevitable – and it seems UK MHRA will emulate New Zealand!

Dec 19, 2019

A single review program for medical devices?

Dec 2, 2019

The door to Europe is closed – so where else should I look?

Dec 2, 2019

Are Harmonised Standards facing irrelevance?

Nov 4, 2019

The question on clients’ lips… “How long will my application take?”

Nov 4, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) AIMD APAC Australia Biocompatibility Biomechanics Brexit CE CE Certificates clinical trials de novo distribution Europe FDA GHTF guidance Harmonization IMDRF IVD IVDD IVDR MDD MDR MDSAP medical device medical devices medicines New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform Reimbursement SaMD Software standards Sterilisation TGA UDI
Translate »